Magnesium (Supplementation)
Magnesium (Supplementation) scored 8.4 / 10 (✅ Top-tier) on the BioHarmony scale as a Substance → Vitamin / Mineral / Nutrient.
What It Is
Magnesium is an essential mineral cofactor in 600+ enzymatic reactions, including ATP production, NMDA receptor modulation, calcium channel regulation, and HPA axis function. It is required for energy metabolism, neurotransmitter synthesis, DNA repair, muscle contraction, and bone mineralization. Despite its foundational role, 50-80% of people eating a Western diet are deficient due to soil depletion, food processing, and increased physiological demand from stress. Supplemental forms vary dramatically in bioavailability: glycinate and citrate absorb well, while oxide is poorly absorbed but cheap. The absorption ceiling is approximately 100-150mg elemental per dose, making split dosing optimal. Type: Supplement (essential mineral) Current status: Nick actively uses magnesium (topical and oral).
How this score is calculated →
Upside (4.05 / 5.00)
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Efficacy | 25% | 3.8 | 0.950 | |
| Breadth of Benefits | 15% | 4.8 | 0.720 | |
| Evidence Quality | 25% | 4.2 | 1.050 | |
| Speed of Onset | 10% | 3.8 | 0.380 | |
| Durability | 10% | 3.2 | 0.320 | |
| Bioindividuality Upside | 15% | 4.2 | 0.630 | |
| Total | 4.050 |
Upside Rationale
Efficacy (3.8/5.0): Magnesium delivers meaningful but not transformative effects across multiple endpoints. Sleep quality improves by PSQI -2.2 to -4.9 points with onset latency reduced by 17 minutes (d~1.1 in elderly per Abbasi 2012, 500mg oxide). Depression responds with PHQ-9 -4.5 points (d~0.65) within just 2 weeks, NNT ~3 (Tarleton 2017). Migraine frequency drops by 1.23 attacks/month (41% reduction, d~0.45, NNT 3-4 for 50% frequency reduction). Blood pressure falls -2.0/-1.78 mmHg overall (Zhang 2016 MA, 34 RCTs), with hypertensives seeing -4.18 mmHg SBP. Fasting glucose drops -4.64 mg/dL with HOMA-IR -0.67 and 36% lower T2D risk at highest intake (Fang 2016, Veronese 2016). Post-surgical AF shows 46% relative risk reduction (NNT 7, Held 2002, Salaminia 2018). No single endpoint is transformative, but the consistency across so many systems is remarkable.
Breadth of Benefits (4.8/5.0): Few supplements touch this many body systems. Sleep, cardiovascular (blood pressure, arrhythmia), metabolic (glucose, insulin sensitivity), neurological (migraine, depression), musculoskeletal (bone density 2-3% higher at highest intake quintile, cramps), and exercise performance (+2.7 mL/kg/min VO2max in deficient subjects). This is near the theoretical ceiling for a single compound.
Evidence Quality (4.2/5.0): The blood pressure meta-analysis alone includes 34 RCTs. Multiple independent meta-analyses exist for glucose metabolism (Fang 2016, Veronese 2016), sleep (Abbasi 2012), migraine (multiple), and depression (Tarleton 2017). Evidence is well-replicated across independent labs. Minor deduction: many older RCTs used poorly-absorbed oxide, which biases effect sizes downward. The Cochrane review on muscle cramps found no benefit, but again, exclusively oxide trials. Strong overall, just short of the creatine ceiling due to fewer total RCTs and some form-confounding.
Speed of Onset (3.8/5.0): Relaxation and muscle effects can be immediate (especially topical). Sleep improvements appear within days. Depression response begins at 2 weeks. Blood pressure effects emerge over weeks. Bone density changes require months. The staggered onset across endpoints means users notice something quickly, which aids compliance.
Durability (3.2/5.0): Benefits persist with continued supplementation. Effects reverse when discontinued because the underlying deficiency returns. This is not a drug dependency issue; it reflects that the body cannot store magnesium long-term and ongoing intake is required to maintain optimal levels. No tolerance development or diminishing returns reported.
Bioindividuality Upside (4.2/5.0): Given that 50-80% of the Western population is deficient, the majority of people will respond. Athletes, elderly individuals, and those under chronic stress show particularly strong responses due to higher magnesium turnover. TRPM6/7 genetic variants modulate absorption and renal handling. Those on PPIs, diuretics, or with high alcohol intake are at especially high risk of deficiency and benefit most from supplementation.
Downside (1.37 / 5.00)
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Safety Risk | 30% | 1.0 | 0.300 | |
| Side Effect Profile | 15% | 1.3 | 0.195 | |
| Financial Cost | 5% | 1.5 | 0.075 | |
| Time/Effort Burden | 5% | — | 0.000 | |
| Opportunity Cost | 5% | — | 0.000 | |
| Dependency / Withdrawal | 15% | 1.2 | 0.180 | |
| Reversibility | 25% | 1.0 | 0.250 | |
| Total | 1.000 | |||
| Harm subtotal × 1.4 | 1.295 | |||
| Opportunity subtotal × 1.0 | 0.075 | |||
| Combined downside | 1.370 | |||
| Baseline offset (constant) | −1.240 | |||
| Effective downside penalty | 0.130 |
Downside Rationale
Safety Risk (1.0/5.0): All common supplemental forms carry GRAS status (pre-DSHEA). The IOM UL of 350mg/day supplemental and EFSA's 250mg/day refer to supplemental magnesium beyond dietary intake, and a 2023 paper argues the 350mg UL is outdated and overly conservative. The body has a built-in GI safety valve: diarrhea occurs well before serum levels approach dangerous territory. Only 40 GI adverse event cases in CAERS over 18 years. Fatal cases cluster exclusively in elderly CKD patients using MgO as a laxative. This is NOT an intrinsic oral risk in healthy adults. Toxicity thresholds (serum >8 mg/dL for DTR loss, >15 mg/dL for cardiac arrest) are essentially unreachable through oral supplementation in anyone with functioning kidneys.
Side Effect Profile (1.3/5.0): GI discomfort is the primary side effect and is entirely form-dependent. Oxide is the worst offender (loose stools, cramping). Glycinate produces nearly zero GI issues. Citrate falls in between. The "side effect" is also the safety mechanism: GI tolerance limits absorption before systemic levels become concerning.
Financial Cost (1.5/5.0): $10-40/month depending on form. Oxide is cheapest but worst-absorbed. Glycinate and citrate run $15-30/month. Threonate (for cognitive applications) is the priciest at $30-40/month. Still inexpensive compared to most health interventions.
Time/Effort Burden (1.0/5.0): One to two capsules daily. Optimal absorption requires splitting doses (100-150mg elemental per sitting), which adds trivial complexity. No food timing requirements, no cycling protocols.
Opportunity Cost (1.0/5.0): Magnesium complements virtually every other supplement and intervention. It is synergistic with vitamin D (required for D metabolism), B6 (co-transport), zinc (complementary mineral), and calcium (antagonist that benefits from proper ratio). It crowds out nothing.
Dependency/Withdrawal (1.2/5.0): No pharmacological dependency. No withdrawal symptoms. No rebound effects. Benefits fade because the underlying deficiency reasserts itself, not because of drug adaptation. This is identical to stopping any essential nutrient.
Reversibility (1.0/5.0): Completely reversible. Stop supplementing and serum/tissue levels return to baseline within days to weeks. No lasting physiological changes to unwind.
Verdict
✅ Best for: Anyone eating a Western diet (50-80% are deficient). People with poor sleep quality. Those experiencing migraines, anxiety, or depression. Athletes and highly-stressed individuals (accelerated magnesium depletion). Elderly populations (reduced absorption, higher need). Anyone on PPIs, diuretics, or other magnesium-depleting medications. Those taking vitamin D (magnesium is required for D metabolism). People seeking the single broadest-benefit, lowest-risk supplement available.
❌ Avoid if: You have chronic kidney disease with GFR <30 (impaired renal clearance creates real toxicity risk). Myasthenia gravis (magnesium worsens neuromuscular junction dysfunction). Heart block (magnesium can worsen conduction delays). Anyone on neuromuscular blocking agents. Separate doses by 2-6 hours from antibiotics (tetracyclines, fluoroquinolones) and bisphosphonates (chelation reduces absorption of both).
How This Score Could Change
BioHarmony scores are living assessments. New research, regulatory changes, or personal context can shift the score up or down. These are the most likely scenarios that would change this intervention's rating.
| Scenario | Dimension Changes | New Score |
|---|---|---|
| Large RCT confirms cognitive benefit of threonate (d>0.5) | Efficacy 3.8 -> 4.2, Breadth 4.8 -> 5.0 | 8.4 / 10 ✅ Top-tier |
| Cochrane update with glycinate trials confirms cramp benefit | Efficacy 3.8 -> 4.0 | 8.3 / 10 ✅ Top-tier |
| New safety signal emerges in healthy population | Safety 1.0 -> 2.0 | 7.9 / 10 💪 Strong recommend |
| Longitudinal RCT shows bone fracture reduction | Breadth 4.8 -> 5.0, Evidence 4.2 -> 4.5 | 8.4 / 10 ✅ Top-tier |
Other interventions for Cardiovascular
See all ratings →📊 How BioHarmony scoring works
BioHarmony translates a weighted expected-value calculation into a reader-facing 0–10 score. 5.0 is neutral (benefits and risks balance). Above 5 = benefits outweigh risks; below 5 = risks outweigh benefits.
Harm-type downsides (safety risk, side effects, reversibility, dependency) carry a 1.4× precautionary multiplier. Harm weighs more than benefit. Opportunity-type downsides (financial cost, time/effort, opportunity cost) are subtracted at face value.
Use case subratings are independent assessments of how well the intervention addresses specific health goals. They are not components of the overall score. Each subrating reflects the scorer's judgment based on use-case-specific evidence, safety, and effect sizes.
Every dimension is evaluated on a 1–5 scale, and the baseline (1) is subtracted before weighting. A perfect intervention with zero downsides contributes zero penalty rather than a residual floor, so top-tier scores are actually reachable.
EV = Upside − Downside
EV = 4.050 − 1.370 = 2.680
EV ranges from −5 to +5. Adding 7 shifts to 2–12, dividing by 12 normalizes to 0–1, then ×10 gives the 0–10 score.
Score = ((2.680 + 7) / 12) × 10 = 8.4 / 10
Further reading
13 BEST Magnesium Supplements Review 2026: Ultimate Guide
Magnesium is one of the few supplements I take every single day. And multiple forms. This guide explains why.
Why You Have Brittle Bones & Heart Issues: The Shocking Truth About Calcium, Omega-3s, Mag L-Threonate, Vitamin B & Other Supplements You Take
Why do so many people still suffer from weak bones, heart issues, & brain fog despite taking supplements daily? Dr. Carolyn Dean reveals the…
